EUVIMEDEUVIMED entdecken
Crossref

Medium chain fatty acids are potent binding competitors to improve protein-bound uremic toxin clearance during hemodialysis

Laure-Anne Raillon, Nans Florens, Florine Payelle, Marie Martin, Laurent Soulère, Dan Yi, Zoé Simon-Onfroy, Stéphane Chambert, Marie Legras, Laurence Chardon, Griet Glorieux, Fitsum Guebre-Egziabher und 1 weitere

Kidney International · 2025

DOI: 10.1016/j.kint.2025.06.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2025. Verfasst von Laure-Anne Raillon und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular, Metabolism, Diabetes and Nutrition (CarMeN), Institut National de la Santé et de la Recherche Médicale (INSERM) U1060, Institut Natio…. Hauptthemen laut MEDLINE: Uremic Toxins, Renal Dialysis, Indican, Cresols. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Université Claude Bernard Lyon 1, Hospices Civils de Lyon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Protein-bound uremic toxins (PBUTs) remain a concerning burden in patients with kidney failure since their removal during hemodialysis is limited due to their tight binding to albumin. Here, we tested whether medium chain fatty acids (MCFAs), potent ligands of human serum albumin (HSA), could be used as binding competitors of PBUTs to increase their removal during a hemodialysis session. METHODS: A simulated hemodialysis session was performed using bovine blood spiked with PBUTs in the presence of various MCFAs. Blood was sampled serially to measure the concentrations of PBUTs indoxyl sulfate (IS) and p-cresyl sulfate (p-CS). RESULTS: The binding of MCFAs to HSA was investigated in silico and using fluorescent probe displacement. The free fraction of IS and p-CS were measured after ultrafiltration of HSA solutions and uremic plasma in the presence of MCFAs (0.25-3 mmol/L). Among the four MCFAs tested, octanoate and decanoate were the most prone to interact with HSA Sudlow site II, one of two main binding sites on HSA. The in vitro incubation of HSA solutions and uremic plasma with MCFAs increased the free fraction of IS and p-CS. The per-dialytic infusion of octanoate significantly improved the fractional removal of p-CS from 38% to 88% and IS from 36% to 91%. CONCLUSIONS: MCFAs can effectively compete with PBUTs for binding to HSA. The per-dialytic administration of octanoate, which strikingly increased the removal of PBUTs, could constitute an efficient and cost-effective strategy to improve the possible clearance of these compounds and prevent their accumulation in patients with kidney failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uremic ToxinsRenal DialysisIndicanCresolsSerum Albumin, HumanSulfuric Acid EstersUremiaToxins, BiologicalFatty AcidsHumansAnimalsCattleCaprylatesProtein BindingBinding, CompetitiveBinding SitesSerum Albumin

Stichwörter der Autor:innen

hemodialysismedium chain fatty acidsprotein bound uremic toxinsuremic toxins

Substanzen

Uremic ToxinsIndican4-cresol sulfateCresolsSerum Albumin, HumanSulfuric Acid EstersCaprylatesoctanoic acidToxins, BiologicalFatty Acids

Autor:innen und Institutionen

  • Cardiovascular, Metabolism, Diabetes and Nutrition (CarMeN), Institut National de la Santé et de la Recherche Médicale (INSERM) U1060, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement…
  • Service de Néphrologie, Centre Hospitalier Universitaire (CHU) de Strasbourg, Université de Strasbourg, Strasbourg, France; Team 3072 "Mitochondria, Oxidative Stress and Muscle Protection," Translational Medicine Federa…
  • Laboratoire Inter-Universitaire de Biologie de la Motricité (LIBM), Equipe d'Accueil 7424, Team Vascular Biology and Red Blood Cell, Université Claude Bernard Lyon 1, Lyon, France.
  • Instititut de Chimie et de Biochimie Moléculaire et Supramoléculaire (ICBMS), Institut National des Sciences Appliquées (INSA)-Lyon, Unité Mixte de Recherche 5246 Centre National de la Recherche Scientifique (CNRS), Uni…
  • Service de Néphrologie, Centre Hospitalier Universitaire (CHU) de Strasbourg, Université de Strasbourg, Strasbourg, France.
  • Laboratoire de Biologie Médicale Multi-Site, Centre de Biologie Est, Groupement Hospitalier Est (GHE), Hospices Civils de Lyon, Bron, France.

Förderung

  • Université Claude Bernard Lyon 1
  • Hospices Civils de Lyon

Zitieren

APA

Raillon, L. A., Florens, N., Payelle, F., Martin, M., Soulère, L., Yi, D., Simon-Onfroy, Z., Chambert, S., Legras, M., Chardon, L., Glorieux, G., Guebre-Egziabher, F., & Soulage, C. O. (2025). Medium chain fatty acids are potent binding competitors to improve protein-bound uremic toxin clearance during hemodialysis. Kidney International. https://doi.org/10.1016/j.kint.2025.06.004

Vancouver

Raillon LA, Florens N, Payelle F, Martin M, Soulère L, Yi D, et al. Medium chain fatty acids are potent binding competitors to improve protein-bound uremic toxin clearance during hemodialysis. Kidney International. 2025. doi:10.1016/j.kint.2025.06.004

BibTeX
@article{Raillon2025,
  author = {Raillon, Laure-Anne and Florens, Nans and Payelle, Florine and Martin, Marie and Soulère, Laurent and Yi, Dan and Simon-Onfroy, Zoé and Chambert, Stéphane and Legras, Marie and Chardon, Laurence and Glorieux, Griet and Guebre-Egziabher, Fitsum and Soulage, Christophe O},
  title = {Medium chain fatty acids are potent binding competitors to improve protein-bound uremic toxin clearance during hemodialysis},
  journal = {Kidney International},
  year = {2025},
  doi = {10.1016/j.kint.2025.06.004}
}
Kostenlos starten →